House Appropriations Committee leaders offer more than criticism of the Food and Drug Administration’s oversight of the US infant formula market during the ongoing supply shortage that followed the shutdown of an Abbott Nutrition plant.
Committee Chairwoman Rosa DeLauro and Rep
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?